Capstone Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,310
Closed -$1.4M 1972
2025
Q2
$1.24M Buy
+2,310
New +$1.1M ﹤0.01% 786
2025
Q1
Sell
-3,528
Closed -$1.46M 1600
2024
Q4
$1.46M Buy
3,528
+1,884
+115% +$826K ﹤0.01% 943
2024
Q3
$831K Sell
1,644
-823
-33% -$400K ﹤0.01% 1031
2024
Q2
$1.2M Sell
2,467
-168
-6% -$84.3K ﹤0.01% 912
2024
Q1
$1.42M Buy
+2,635
New +$1.44M 0.01% 953
2023
Q4
Sell
-1,500
Closed -$704K 2239
2023
Q3
$656K Buy
1,500
+1,301
+654% +$649K ﹤0.01% 1182
2023
Q2
$99.9K Buy
199
+155
+352% +$74.3K ﹤0.01% 1698
2023
Q1
$22K Buy
+44
New +$21.1K ﹤0.01% 1458
2022
Q4
Sell
-7,157
Closed -$2.78M 1575
2022
Q3
$2.33M Buy
7,157
+4,929
+221% +$1.81M 0.01% 702
2022
Q2
$781K Buy
+2,228
New +$909K ﹤0.01% 1098
2022
Q1
Sell
-70
Closed -$36.8K 2108
2021
Q4
$46K Sell
70
-6,779
-99% -$4.26M ﹤0.01% 1744
2021
Q3
$4.26M Buy
+6,849
New +$4.6M 0.01% 909
2020
Q1
Sell
-2,115
Closed -$552K 1256
2019
Q4
$552K Buy
+2,115
New +$557K ﹤0.01% 1124
2018
Q4
Sell
-443
Closed -$90.8K 1306
2018
Q3
$111K Buy
+443
New +$108K ﹤0.01% 1125
2017
Q3
Sell
-20,426
Closed -$3.3M 640
2017
Q2
$3.3M Sell
20,426
-12,574
-38% -$2.04M 0.09% 190
2017
Q1
$5.1M Buy
+33,000
New +$4.55M 0.13% 134
2016
Q4
Sell
-21,060
Closed -$2.37M 1021
2016
Q3
$2.37M Buy
21,060
+1,192
+6% +$126K 0.05% 234
2016
Q2
$1.84M Buy
+19,868
New +$1.71M 0.04% 248

Other funds holding IDXX

Capstone Investment Advisors's IDXX Position: Q3 2025 in Review

Capstone Investment Advisors sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 2,310 shares — an estimated $1.4M sold.

Capstone Investment Advisors first reported a position in IDXX in Q2 2016 and held it in 18 quarters. The position peaked at $5.1M in Q1 2017. 1,303 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

  • Capstone Investment Advisors reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 2,310 Idexx Laboratories shares in Q3 2025, an estimated $1.4M.
  • Capstone Investment Advisors first reported a position in Idexx Laboratories in Q2 2016 and held it in 18 quarters.
  • Capstone Investment Advisors's Idexx Laboratories position peaked at $5.1M in Q1 2017.
  • 1,303 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Capstone Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.